Gabriela-Dumitrita Stanciu

2 papers in the library · 6 citations · publishing 2025

Papers

Sort Most recent Most cited

Psychedelic interventions for major depressive disorder in the elderly: Exploring novel therapies, promise and potential.

Dialogues in Clinical Neuroscience December 1, 2025 Ivona-Maria Tudorancea, Gabriela-Dumitrita Stanciu, Carla Torrent et al. 4 citations

The global population is ageing rapidly, with the number of individuals aged 60 and older reaching 1 billion in 2019 and expected to double by 2050. As people age, neuropsychological health often deteriorates, leading to a higher prevalence of age-related depression. Symptoms may include anxiety, apathy, mood instability, sadness, and, in severe cases, suicidal thoughts. Depression in the...

DOI: 10.1080/19585969.2025.2499458 Full text Psychedelic-assisted therapy Age-related comorbidities Ageing and depression Mental health care +6

Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?

Dialogues in Clinical Neuroscience March 19, 2025 Michael Davidson, Gabriela-Dumitrita Stanciu, Jonathan Rabinowitz et al. 2 citations

The increasing prevalence of dementia within an ageing global population, combined with prolonged life expectancy, accentuates Alzheimer's disease (AD) as a multifaceted healthcare challenge. This challenge is further compounded by the limited therapeutic options currently available. Addressing the intricacies of AD management, the mitigation of comorbidities has emerged as a pivotal facet of...

DOI: 10.1080/19585969.2025.2480566 Full text Psychedelics Mental health Alzheimer's disease Brain research